The spokesperson of Aurobindo Pharma said there are no repeat observations or anything related to data integrity and that they are in the process of submitting a response to the USFDA.
Subscribe to:
Post Comments (Atom)
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
No comments:
Post a Comment